title: Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.
abstract: Noonan syndrome (NS) is a common multiple congenital anomaly entity, the diagnosis of which, on clinical grounds, is based on a comprehensive scoring system in order to select patients for molecular confirmation. Our aim was to evaluate the phenotypic characteristics in the light of PTPN11 mutations. The study revealed 80 patients who were referred with initial indication of NS or Noonan-like syndrome (NLS) and further assessed by a clinical geneticist; 60/80 index patients, mean age 5.9 ± 5.3 years, fulfilled the NS criteria. Molecular analysis of PTPN11 gene (exons and their flanking regions) of the total population revealed mutations in 17/80 patients, all belonging in the group of the patients screened with the scoring system. All mutations were heterozygous missense changes, mostly clustering in exon 3 (8/17), followed by exons 13 (3/17), 8 (2/17), 7 (2/17), 2 (1/17) and 4 (1/17). We conclude that (a) most of our clinically diagnosed NS cases were sporadic (b) PTPN11 analysis should be limited to those fulfilling the relevant NS criteria (c) Cardiovascular evaluation should comprise all NS patients, while pulmonary stenosis, short stature, and thorax deformities prevailed among those with PTPN11 mutations.
authors: 3rd Department of Pediatrics, University General Hospital Attikon, University of Athens, Athens, Greece. anpapado@med.uoa.gr
authors: Anna
authors: A
authors: Papadopoulou
authors: Michalis
authors: M
authors: Issakidis
authors: Evangelia
authors: E
authors: Gole
authors: Konstantina
authors: K
authors: Kosma
authors: Helen
authors: H
authors: Fryssira
authors: Andreas
authors: A
authors: Fretzayas
authors: Polyxeni
authors: P
authors: Nicolaidou
authors: Sophia
authors: S
authors: Kitsiou-Tzeli
references: Horm Res. 2009;71(4):185-93
references: 19258709
references: Pediatr Hematol Oncol. 1995 Nov-Dec;12(6):571-5
references: 8589002
references: Trends Biochem Sci. 2003 Jun;28(6):284-93
references: 12826400
references: J Med Genet. 1995 Sep;32(9):743-5
references: 8544198
references: Front Biosci. 2008 May 01;13:4925-32
references: 18508557
references: Nat Genet. 2001 Dec;29(4):465-8
references: 11704759
references: J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):523-7
references: 10598665
references: Horm Res. 2006;66(3):124-31
references: 16804314
references: Nat Genet. 2007 Jan;39(1):70-4
references: 17143285
references: Clin Endocrinol (Oxf). 2008 Sep;69(3):426-31
references: 18331608
references: Hum Mutat. 2010 Mar;31(3):284-94
references: 20052757
references: Nat Genet. 2006 Mar;38(3):331-6
references: 16474405
references: J Pediatr. 2004 Mar;144(3):368-74
references: 15001945
references: Nat Genet. 2009 Sep;41(9):1022-6
references: 19684605
references: Eur J Med Genet. 2008 Nov-Dec;51(6):566-72
references: 18678287
references: Nat Genet. 2010 Jan;42(1):27-9
references: 19966803
references: Am J Med Genet A. 2010 Nov;152A(11):2768-74
references: 20954246
references: Eur J Pediatr. 2008 Sep;167(9):1025-31
references: 18057963
references: J Med Genet. 2007 Dec;44(12):763-71
references: 17704260
references: J Hum Genet. 2008;53(11-12):999-1006
references: 19020799
references: Eur J Hum Genet. 2003 Feb;11(2):201-6
references: 12634870
references: Am J Med Genet. 1985 Jul;21(3):493-506
references: 3895929
references: Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):274-9
references: 17639592
references: Genet Test Mol Biomarkers. 2010 Jun;14(3):425-32
references: 20578946
references: Neuromuscul Disord. 2010 Jan;20(1):61-3
references: 19875288
references: Pediatr Radiol. 1997 Apr;27(4):324-6
references: 9162899
references: Nat Genet. 2007 Aug;39(8):1007-12
references: 17603483
references: Nat Genet. 2007 Jan;39(1):75-9
references: 17143282
references: Arq Bras Endocrinol Metabol. 2007 Apr;51(3):450-6
references: 17546245
references: South Med J. 2001 Apr;94(4):432-4
references: 11332913
references: Am J Med Genet. 1985 Jul;21(3):507-14
references: 4025385
references: Am J Med Genet A. 2005 Apr 15;134A(2):165-70
references: 15723289
references: J Med Genet. 2007 Oct;44(10):651-6
references: 17586837
references: Am J Med Genet A. 2010 Aug;152A(8):1960-6
references: 20602484
references: Am J Med Genet A. 2010 Sep;152A(9):2176-84
references: 20683980
references: Am J Hum Genet. 2002 Jun;70(6):1555-63
references: 11992261
references: Eur J Med Genet. 2005 Apr-Jun;48(2):81-96
references: 16053901
references: Am J Med Genet. 1991 Aug 1;40(2):159-66
references: 1897569
references: J Med Genet. 2008 Dec;45(12):832
references: 19047498
references: Genet Test. 2006 Fall;10(3):186-91
references: 17020470
references: Mol Syndromol. 2010 Feb;1(1):2-26
references: 20648242
references: Cell Signal. 2008 Mar;20(3):453-9
references: 17993263
references: Am J Hum Genet. 2010 Aug 13;87(2):250-7
references: 20619386
references: Nat Genet. 2007 Aug;39(8):1013-7
references: 17603482
references: Am J Med Genet. 1994 Nov 1;53(2):187-91
references: 7856646
references: J Clin Endocrinol Metab. 2004 Jul;89(7):3359-64
references: 15240615
references: Am J Med Genet. 1981;10(1):37-50
references: 7294061
references: Pediatrics. 2007 Jun;119(6):e1325-31
references: 17515436
references: Pediatrics. 2010 Oct;126(4):746-59
references: 20876176
references: J Pediatr Hematol Oncol. 2007 May;29(5):341-4
references: 17483716
references: J Pediatr Hematol Oncol. 2003 Apr;25(4):330-2
references: 12679651
references: Am J Dis Child. 1974 Jan;127(1):48-55
references: 4809794